Himuka AM Pharma
himuka-am.com
Actively hiring
Health Care
Clinical Research
Pharmaceuticals
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Himuka AM Pharma develops drug candidates derived from adrenomedullin (AM), a bioactive peptide originally discovered at the University of Miyazaki. The company focuses on creating peptide derivatives and drug seeds intended to address unmet medical needs in vascular, inflammatory and organ-protective conditions. It is a Japanese biotechnology company developing AM-based therapeutics for clinical and pharmaceutical markets.